New Research into Dyskinesia Drug announced

Written by P. Brady

Published: November 30, 2020

Parkinson’s UK is joining forces with US Charity The Michael J. Fox Foundation and biopharma company Neurolixis to fund a £1.5 m clinical trial of an exciting new drug to combat Dyskinesia in people with Parkinson’s.

Featured image by Michael Longmire on Unsplash

You may also like…

Christmas Lunch 2022

Christmas Lunch 2022

Our Christmas lunch this year is to be held at Dunnings Mill, East Grinstead on 7th December.  The cost of our...

read more